Weight loss, diabetes drugs can protect kidneys: Study

Research team found that GLP-1 receptor agonists decreased the risk of kidney failure by 16 per cent compared to placebo

The popular glucagon-like peptide-1 (GLP-1) receptor agonists known to help in weight loss as well as manage blood sugar can also protect the kidneys, regardless of diabetes status, finds a study led by an Indian-origin researcher. Originally developed to treat diabetes, GLP-1 receptor agonists have significant benefits in people with and without diabetes, according to the study published in The Lancet Diabetes and Endocrinology.

The drug stimulates insulin production and lowers blood sugar levels by mimicking the action of a hormone called glucagon-like peptide 1. It also slows down digestion, increases feelings of fullness, and reduces hunger to aid in weight loss.